Protagonist Therapeutics, Inc. (PTGX) compared with its closest peers (AQST, CPIX, XLO, PVLA, LXRX). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Aquestive Therapeutics, Cumberland Pharmaceuticals, Xilio Therapeutics, Palvella Therapeutics, Lexicon Pharmaceuticals, Ocular Therapeutix, XOMA Royalty, Enveric Biosciences, Q32 Bio and Agios Pharmaceuticals share Protagonist Therapeutics's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | $583.63M | -8.4 |
| Cumberland Pharmaceuticals Inc. (CPIX) | $114.10M | -20.5 |
| Xilio Therapeutics, Inc. (XLO) | $52.68M | -0.2 |
| Palvella Therapeutics, Inc. (PVLA) | $2.04B | -28.2 |
| Lexicon Pharmaceuticals, Inc. (LXRX) | $1.03B | -8.1 |
| Ocular Therapeutix, Inc. (OCUL) | $2.43B | -8.5 |
| XOMA Royalty Corp. (XOMA) | $505.65M | 16.8 |
| Enveric Biosciences, Inc. (ENVB) | $6.36M | -0.1 |
| Q32 Bio Inc. (QTTB) | $270.79M | 1.4 |
| Agios Pharmaceuticals, Inc. (AGIO) | $1.97B | -3.8 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
PTGX overview · PTGX earnings · PTGX financials · PTGX KPIs · PTGX documents · PTGX ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.